CORRELATION BETWEEN SMOKING AND SEVERITY OF SARS-COV-2 INFECTION AMONG IRAQI POPULATION

Authors

Dhuha Ali Hassan 1Department of Medical Microbiology, College of Medicine, University of Al-Qadisiyah, Al-Diwaniya, Iraq
Manal Mohammed Kadhim Medical Microbiology-Clinical Immunology Specialist at Department of Medical Microbiology, College of Medicine, University of Al-Qadisiyah, Al-Diwaniya, Iraq

Keywords:

ACE-2 receptor, Active smoking, Iraqi population, SARS-COV2 infection

Abstract

Smoking regarded an important predisposing factor for cardiovascular and pulmonary disease and known risk factor for severe outcomes and death result from respiratory infection. This study aims to quantify the correlation between smoking and COVID-19 disease progression. This cross-sectional study done on 200 COVID-19 patients have been recruited from Al-Diwaniyah teaching hospital, Iraq in period of 1st of November, 2020 to the end of February, 2021, to assess the effect of smoking on susceptibility and/or clinical symptoms of SARS-COV2 infection. The study reveals no significant correlation between smoking and susceptibility nor with severity of disease (p = 0.231). During the time of this study, no strong evidence was available suggest that smoking have an effect on severity of SARS-COV2 infection. Smoking is not a risk factor for having bad COVID-19progression. even if one might have anticipated the opposite. Thus, the epidemiological data seem to question the role of coexisting active smoking as a risk factor for COVID-19 pneumonia

References

Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM et al., 2020. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS One. May 11;15(5): e0233147. doi: 10.1371/journal. Pone .0233147. PMID: 32392262; PMCID: PMC7213702.

Azer S, (2020). COVID-19: pathophysiology, diagnosis, complication and investigational therapeutics. New Microbes New Infect. Sep; 37:100738. doi: 10.1016/j.nmni.2020.100738. PMID: 32834902; PMCID: PMC7403867.

Cai G, 2020. Tobacco-Use Disparity in Gene Expression of ACE2, the Receptor of 2019-nCov. 10.20944/preprints202002. 0051.v1.

Caussy C, Pattou F, Wallet F, Simon C, Chalopin S, et al., (2020). Prevalence of obesity among adult inpatients with COVID-19 in France. Lancet Diabetes Endocrinol. Jul;8(7):562-564. doi:10.1016/S22138587 (20)30160-1. PMID: 32437642; PMCID: P M C 7 2 3 4780.

Chen N, Zhou M, Dong X Qu J, et al., (2020). Epidemiological and Clinical Characteristics of 99 Cases of 2019-Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China a descriptive study. Lancet 395 (10223): P. 506-513.doi.10.2139/ssrn.3523861.

Coutard B, V. C., lAMBALLENE x., Canard B., Seidah N., Decroly E., (2020). "The spike glycoprotein of the new coronavirus 2019-nCov contains a furin-like cleavage site absent in CoV of the SAME CLADE." Antivir. Res: 176.

Farsalinos, K., Bagos, P.G., Giannouchos, T. et al., (2021). Smoking prevalence among hospitalized COVID-19 patients and its association with disease severity and mortality: an expanded re-analysis of a recent publication. Harm Reduct J. 18, 9. doi.org/10.1186/s12954-020-00437-5.

Favare G., Pomar I., Musso D, et al., (2020). 2019-nCov epidemic: What about pregnancies? Lancet; 395(10224): e40. Feb;24(4):2006-2011. doi: 10.26355/eurrev_202002_20378. PMID: 32141569.

Guan, W. J., Liang, W. H., Zhao, Y., Liang, H. R., Chen, Z. S et al., (2020). China Medical Treatment Expert Group for COVID-19 (2020). Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. The European respiratory journal, 55(5), 2000547. https://doi.org/10.1183/13993003.00547-2020.

https://covid19.who.int.

Hu D, Lou X, Meng N et al., (2021). Influence of age and gender on the epidemic of COVID-19. Wien Klin Wochenschr 133,321-330. Doi:10.1007/s00508-021-01816-z.

Kannan U., P. M. O., Stertz S. (2020). "Breaking the coronavirus: sialoglycan variants, coreceptors, and alternative receptors for influenza a virus entry." J. Virol.: 94.

Karanasos A, Aznaouridis K, Latsios G et al., (2020). Impact of Smoking Status on Disease Severity and Mortality of Hospitalized Patients With COVID-19 Infection: A Systematic Review and Meta-analysis. Nicotine Tob Res. 2020 Aug 24;22(9):1657-1659. doi: 10.1093/ntr/ntaa107. PMID: 32564072; PMCID: PMC7337737.

Keni Raghuvir, Alexander Anila, Nayak Pawan Ganesh, et al., (2020). COVID-19: Emergence, Spread, Possible Treatments, and Global Burden. Frontiers in Public Health. 8. DOI=10.3389/fpubh.2020.00216. ISSN=2296-2565

Krishnan, A., Hamilton, J. P., Alqahtani, S. A., & Woreta, T. A. (2021). COVID-19: An overview and a clinical update. World journal of clinical cases, 9(1), 8–23. doi.org/10.12998/wjcc. v9.i1.8

Li Q, G. X., Wu P. Wang X. Zhou L, Tong Y, et al., (2020). "Early transmission dynemics in Wuhan, China of novel coronpvirus infected pnemonia." N Eng/J Med 382: 1199-1207.

Mo P, Xing Y, Xiao Y, et al., (2020). Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clinical Infectious Diseases. DOI: 10.1093/cid/ciaa270.

Mohsin, F. M., Tonmon, T. T., Nahrin, R., Tithy, S. A et al., (2021). Association Between Smoking and COVID-19 Severity: Evidence from Bangladesh. Journal of multidisciplinary healthcare, 14, 1923–1933. https://doi.org/10.2147/JMDH.S317603

Ong SWX, Chiew CJ, Ang LW, Mak TM, Cui L, Toh MPHS, Lim YD, Lee PH, Lee TH, Chia PY, Maurer-Stroh S, Lin RTP, Leo YS, Lee VJ, Lye Qu Hong, Chen Yong fang, Zeng Wenjing, Huang Xiaohua., et al., (2020). Polymorphisms in FCGR2A (131H/R) and FCGR2B (232I/T) are associated with the development of inhibitors in Chinese hemophilia A patients. doi:10.21203/rs.3.rs-35124/v1.

Polverino Francesca, 2020. Cigarette Smoking and COVID-19: A Complex Interaction. American Journal of Respiratory and Critical Care Medicine. Yune12, (202); 3. Doi: 10.1164/ rccm.202005-1646LE. PubMed: 32530714.

Prompetchara E., Ketloy C., Palaga T, et al., (2020). Immune response in COVID-19 and potential vaccines: Lesson learned from SARS and MERS epidemic. Asian Pacific Journal of Allergy and Immunity. Doi: 10.12932/AP.200220-0772. (February).

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, et al., (2020). Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.PM ID: 32320003; PMCID: PMC7177629.

van Zyl-Smit, R. N., Richards, G., & Leone, F. T. (2020). Tobacco smoking and COVID-19 infection. The Lancet. Respiratory medicine, 8(7), 664–665. https://doi.org/10.1016/S2213-2600(20)30239-3.

Vardavas, C. I., & Nikitara, K. (2020). COVID-19 and smoking: A systematic review of the evidence. Tobacco induced diseases, 18, 20. https://doi.org/10.18332/tid/119324.

WHO, (2020, march 14)? "Statement on the second meeting of the international health regulations (2005). Emergency Committee regarding the outbreak of novel coronavirus (2019n Cov). (2020)."

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, et al., (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. May; 4:91-95. doi: 10.1016/j.ijid.2020.03.017.PMID:32173574; PMCID: PMC7194638.

Ye, Z. W., Yuan, S., Yuen, K. S., Fung, S. Y., Chan, C. P., & Jin, D. Y. (2020). Zoonotic origins of human coronaviruses. International journal of biological sciences, 16(10), 1686–1697. https://doi.org/10.7150/ijbs.45472.

Downloads

Published

2022-05-28

How to Cite

Dhuha Ali Hassan, & Manal Mohammed Kadhim. (2022). CORRELATION BETWEEN SMOKING AND SEVERITY OF SARS-COV-2 INFECTION AMONG IRAQI POPULATION. European Journal of Research Development and Sustainability, 3(5), 62-67. Retrieved from https://scholarzest.com/index.php/ejrds/article/view/2267